Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors
Neuroendocrinology · 2023
DOI: 10.1159/000535385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroendocrinology, 2023. Verfasst von Man Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, liumanjx@163.com. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, T-Lymphocytes, Regulatory, Pancreatic Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The aim of this study was to investigate the role of circulating regulatory T cells (Tregs) as a novel marker associated with liver metastases and treatment response to transarterial embolization (TAE) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Methods
Circulating Tregs, defined as the CD4+CD25+CD127low/− population, were examined by flow cytometry in peripheral blood mononuclear cells from patients with GEP-NETs. Clinicopathological parameters, radiologic response, and hepatic progression-free survival (hPFS) data were collected.
Results
The association between circulating Tregs and clinicopathological parameters was analyzed in 139 GEP-NET patients. Higher Treg levels were significantly associated with more progressive clinical features, including a higher WHO grade, more advanced TNM stage, and the presence of liver metastases. A Treg level ≥8.015% distinguished between patients with and without liver metastases. Among a cohort of 51 GEP-NET patients who were subjected to TAE for reducing liver metastasis burden, patients with higher Treg levels depicted unfavorable responses and significantly reduced hPFS after TAE treatment. We also revealed that patients with Treghigh (≥8.975%) displayed significantly shorter median hPFS than patients with Treglow (<8.975%). Additionally, after adjusting for other confounding clinical parameters, the association between Tregs and treatment response as well as hPFS remained significant, suggesting that Tregs may have a strong and independent prognostic impact in GEP-NETs.
Conclusion
Our data suggest that circulating Tregs are a novel immunological marker associated with liver metastases and treatment response to TAE in patients with GEP-NETs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, liumanjx@163.com.
- Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Zitieren
APA
Liu, M., Yu, H., Chen, L., Yang, D., Liu, H., Ouyang, J., Zhang, J., Yan, X., Luo, Y., Lin, Y., He, Q., Chen, M., Zhang, N., & Wang, Y. (2023). Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. https://doi.org/10.1159/000535385
Vancouver
Liu M, Yu H, Chen L, Yang D, Liu H, Ouyang J, et al. Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. 2023. doi:10.1159/000535385
BibTeX
@article{Liu2023,
author = {Liu, Man and Yu, Hang and Chen, Luohai and Yang, Dequan and Liu, Haikuan and Ouyang, Juan and Zhang, Jiang and Yan, Xu and Luo, Yanji and Lin, Yuan and He, Qiao and Chen, Minhu and Zhang, Ning and Wang, Yu},
title = {Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors},
journal = {Neuroendocrinology},
year = {2023},
doi = {10.1159/000535385}
}
EUVIMED